Bb Biotech as of March 31, 2019
Portfolio Holdings for Bb Biotech
Bb Biotech holds 35 positions in its portfolio as reported in the March 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ionis Pharmaceuticals (IONS) | 15.8 | $627M | 7.7M | 81.17 | |
Incyte Corporation (INCY) | 7.8 | $311M | 3.6M | 86.01 | |
Neurocrine Biosciences (NBIX) | 7.5 | $297M | 3.4M | 88.10 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 6.0 | $239M | 1.3M | 183.95 | |
Sage Therapeutics (SAGE) | 5.5 | $219M | 1.4M | 159.05 | |
Celgene Corporation | 5.2 | $208M | 2.2M | 94.34 | |
Agios Pharmaceuticals (AGIO) | 5.0 | $201M | 3.0M | 67.44 | |
Alexion Pharmaceuticals | 4.5 | $178M | 1.3M | 135.18 | |
Alnylam Pharmaceuticals (ALNY) | 3.8 | $152M | 1.6M | 93.45 | |
Esperion Therapeutics (ESPR) | 3.6 | $141M | 3.5M | 40.15 | |
Radius Health | 3.4 | $135M | 6.8M | 19.94 | |
Halozyme Therapeutics (HALO) | 3.4 | $134M | 8.3M | 16.10 | |
Argenx Se (ARGX) | 2.8 | $113M | 905k | 124.84 | |
Moderna (MRNA) | 2.5 | $97M | 4.8M | 20.35 | |
Myovant Sciences | 2.2 | $86M | 3.6M | 23.87 | |
Intercept Pharmaceuticals In | 2.0 | $78M | 697k | 111.86 | |
Gilead Sciences (GILD) | 1.9 | $74M | 1.1M | 65.01 | |
Nektar Therapeutics (NKTR) | 1.7 | $68M | 2.0M | 33.60 | |
Exelixis (EXEL) | 1.7 | $68M | 2.8M | 23.80 | |
Akcea Therapeutics Inc equities | 1.7 | $67M | 2.4M | 28.33 | |
Myokardia | 1.6 | $66M | 1.3M | 51.99 | |
Macrogenics (MGNX) | 1.5 | $61M | 3.4M | 17.98 | |
Wave Life Sciences (WVE) | 1.4 | $57M | 1.5M | 38.85 | |
Voyager Therapeutics (VYGR) | 1.4 | $55M | 2.9M | 19.14 | |
Audentes Therapeutics | 1.3 | $53M | 1.4M | 39.02 | |
Alder Biopharmaceuticals | 0.9 | $38M | 2.8M | 13.65 | |
Crispr Therapeutics (CRSP) | 0.7 | $29M | 811k | 35.72 | |
Scholar Rock Hldg Corp (SRRK) | 0.7 | $28M | 1.5M | 18.79 | |
Intra Cellular Therapies (ITCI) | 0.7 | $27M | 2.2M | 12.18 | |
Sangamo Biosciences (SGMO) | 0.6 | $25M | 2.7M | 9.54 | |
Kezar Life Sciences (KZR) | 0.5 | $22M | 1.2M | 17.74 | |
G1 Therapeutics | 0.3 | $11M | 672k | 16.60 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $6.1M | 2.3M | 2.65 | |
Novavax | 0.1 | $4.6M | 8.3M | 0.55 | |
Homology Medicines | 0.1 | $2.5M | 91k | 27.73 |